Stopped: Study terminated to to shortage if study supplies for epidurals and most enrolled has study deviations due to not receiving correct post study drug assignments.
Gabapentin is a nerve medication that treats pain. The specific aim of the study is to compare the difference in the postoperative use of no gabapentin, 300 mg gabapentin 3x daily, or 300 mg gabapentin once at night. Our hypothesis is that higher doses of gabapentin will correlate with decreased pain at the incision and chest tube sites and decreased opioid consumption.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The Primary Endpoint of This Study Will be Incision and Chest Tube Site Pain Scores.
Timeframe: 1 hour after surgery
The Primary Endpoint of This Study Will be Incision and Chest Tube Site Pain Scores.
Timeframe: 24 hour after surgery
The Primary Endpoint of This Study Will be Incision and Chest Tube Site Pain Scores.
Timeframe: 48 hour after surgery
The Primary Endpoint of This Study Will be Incision and Chest Tube Site Pain Scores.
Timeframe: 72 hour after surgery
The Primary Endpoint of This Study Will be Incision and Chest Tube Site Pain Scores.
Timeframe: 96 hour after surgery